Literature DB >> 27928399

Spectrum and Clinical Course of Visual Field Abnormalities in Ethambutol Toxicity.

Thomas Mendel1, David Fleischman2, R Rand Allingham3, Henry Tseng3, David A Chesnutt2.   

Abstract

Visual toxicities from ethambutol are rare but represent one of the few causes of non-glaucomatous and non-compressive bitemporal hemianopsia. The authors present a six-patient case series illustrating variable clinical presentation and reversibility of visual loss in patients treated with ethambutol for Mycobacterium avium complex, including four patients who presented with visual field defects suggestive of bitemporal hemianopsia. Two additional patients were being followed for glaucoma, developed visual field defects with ethambutol treatment, and subsequently recovered with cessation of drug. In patients being treated with ethambutol, reversible bitemporal hemianopsia was the most commonly noted presentation of ethambutol toxicity.

Entities:  

Keywords:  Bitemporal; Mycobacterium; ethambutol; hemianopsia; toxicity

Year:  2016        PMID: 27928399      PMCID: PMC5123087          DOI: 10.3109/01658107.2016.1173065

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  20 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year.

Authors:  Alfredo A Sadun; Michelle Y Wang
Journal:  J Neuroophthalmol       Date:  2008-12       Impact factor: 3.042

Review 3.  Ethambutol: a review with special reference to ocular toxicity.

Authors:  K M Citron
Journal:  Tubercle       Date:  1969-03

4.  Risk Factors for Central Nervous System Tuberculosis.

Authors:  Alexandra Duque-Silva; Katherine Robsky; Jennifer Flood; Pennan M Barry
Journal:  Pediatrics       Date:  2015-10-05       Impact factor: 7.124

5.  Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a prospective study.

Authors:  Jawahar Lal Goyal; N P Singh; Amit Bhatia
Journal:  J Commun Dis       Date:  2003-12

6.  Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.

Authors:  Christopher I Zoumalan; Madhu Agarwal; Alfredo A Sadun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-23       Impact factor: 3.117

7.  A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.

Authors:  M Pierce; S Crampton; D Henry; L Heifets; A LaMarca; M Montecalvo; G P Wormser; H Jablonowski; J Jemsek; M Cynamon; B G Yangco; G Notario; J C Craft
Journal:  N Engl J Med       Date:  1996-08-08       Impact factor: 91.245

8.  Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

Authors:  S D Nightingale; D W Cameron; F M Gordin; P M Sullam; D L Cohn; R E Chaisson; L J Eron; P D Sparti; B Bihari; D L Kaufman
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

9.  Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway.

Authors:  J E Heng; C K Vorwerk; E Lessell; D Zurakowski; L A Levin; E B Dreyer
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-01       Impact factor: 4.799

10.  Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Authors:  R E Chaisson; R D Moore; D D Richman; J Keruly; T Creagh
Journal:  Am Rev Respir Dis       Date:  1992-08
View more
  1 in total

1.  Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy.

Authors:  Rohit Saxena; Digvijay Singh; Swati Phuljhele; V Kalaiselvan; Satya Karna; Rashmin Gandhi; Anupam Prakash; Rakesh Lodha; Anant Mohan; Vimla Menon; Rajeev Garg
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.